Amongst 7,039 conditions reviewed, the difference in the prevalence of 67% of conditions in these two databases was reduced after standardization.
In total, amongst 7,039 conditions reviewed, the difference in the prevalence of 67% of conditions in these two databases was reduced after standardization, while 23% of condition prevalence estimates did not change after standardization.
This paper is to review the differences in the developments of microfluidic chips for extracting genomic deoxyribonucleic acid (DNA) and viral ribonucleic acid (RNA) from blood by the Biosensor Focus Interest Group BFIGG) in Singapore.
After reviewing the differences in the bilateral relationship, then and now, he asked rather pointedly, "What happened to account for this change and where will it lead us?" The journalist recalled that when he had appeared at the group's founding conference, in 2010, relations were at an all-time low.
On base of the recently updated Cochrane review the difference in risk for PPH after CS (defined as blood loss >500 ml or as defined by trialist) between carbetocin and oxytocin did not reach statistical significance (risk ratio (RR) 0.66; 95 % confidence interval (CI) 0.42 1.06, p = 0.086).
Clinical heterogeneity will be assessed by reviewing the differences across trials in characteristics of randomised patients.
Guilherme and colleagues [ 6, 9, 33] have reviewed the ethnic differences in DR genotypes involved in predisposition for RF.
In both reviews, the differences in bone loss after 12 months are in a range below a tenths of a millimeter and most probably not clinically relevant.
In this review, the differences in PSA screening practice, reported incidence and prognosis of prostate cancer, and genetic factors between the populations in East and West factors are discussed.
